• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单链抗癌胚抗原抗体在细胞毒性T淋巴细胞中的表达。Fas配体介导的结肠癌重定向裂解。

Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma.

作者信息

Darcy P K, Kershaw M H, Trapani J A, Smyth M J

机构信息

Cellular Cytotoxicity Laboratory, The Austin Research Institute, Heidelberg, Victoria, Australia.

出版信息

Eur J Immunol. 1998 May;28(5):1663-72. doi: 10.1002/(SICI)1521-4141(199805)28:05<1663::AID-IMMU1663>3.0.CO;2-L.

DOI:10.1002/(SICI)1521-4141(199805)28:05<1663::AID-IMMU1663>3.0.CO;2-L
PMID:9603473
Abstract

In the MD45 mouse cytotoxic T lymphocyte (CTL) hybridoma cell line, we have expressed a chimeric receptor, consisting of the single-chain variable domains (scFv) of anti-carcinoma embryonic antigen (CEA) mAb linked to Fcgamma receptor (FcgammaR) chain via a CD8 hinge. Transfected MD45 subclones lysed CEA-positive human colon carcinoma cell lines in an antigen-specific and FasL-dependent manner. The degree of lysis correlated with the level of chimeric receptor expressed on transduced MD45 subclones. The requirement for an intact Y65TGL motif in the signaling gamma chain suggested that interaction of the chimeric receptor with target cell CEA induced the cytotoxicity of MD45-scFv subclones. However, MD45 expressing a Y65F mutant chimera still displayed minor levels of lysis following PMA stimulation, suggesting that PMA could bypass gamma chain induction of functional FasL. Pretreatment of Fas-resistant CEA-positive colon carcinoma target cells with IFN-gamma increased their sensitivity of MD45-scFv subclones and FasL-mediated lysis. This study has demonstrated the successful activation of FasL function via a chimeric receptor introduced into lymphocytes and the susceptibility of human colon carcinoma to combined cytokine and CTL treatment.

摘要

在MD45小鼠细胞毒性T淋巴细胞(CTL)杂交瘤细胞系中,我们表达了一种嵌合受体,它由抗癌胚抗原(CEA)单克隆抗体的单链可变区(scFv)通过CD8铰链区与Fcγ受体(FcγR)链相连组成。转染的MD45亚克隆以抗原特异性和FasL依赖的方式裂解CEA阳性的人结肠癌细胞系。裂解程度与转导的MD45亚克隆上表达的嵌合受体水平相关。信号γ链中完整的Y65TGL基序的需求表明嵌合受体与靶细胞CEA的相互作用诱导了MD45-scFv亚克隆的细胞毒性。然而,表达Y65F突变嵌合体的MD45在PMA刺激后仍显示出较低水平的裂解,这表明PMA可以绕过γ链对功能性FasL的诱导。用IFN-γ预处理对Fas耐药的CEA阳性结肠癌靶细胞可增加其对MD45-scFv亚克隆和FasL介导的裂解的敏感性。本研究证明了通过引入淋巴细胞的嵌合受体成功激活FasL功能以及人结肠癌对细胞因子和CTL联合治疗的敏感性。

相似文献

1
Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma.单链抗癌胚抗原抗体在细胞毒性T淋巴细胞中的表达。Fas配体介导的结肠癌重定向裂解。
Eur J Immunol. 1998 May;28(5):1663-72. doi: 10.1002/(SICI)1521-4141(199805)28:05<1663::AID-IMMU1663>3.0.CO;2-L.
2
Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.经体外基因工程改造的细胞毒性T淋巴细胞对结肠癌进行重定向穿孔素依赖性裂解
J Immunol. 2000 Apr 1;164(7):3705-12. doi: 10.4049/jimmunol.164.7.3705.
3
Fas-ligand-mediated lysis of erbB-2-expressing tumour cells by redirected cytotoxic T lymphocytes.通过重定向细胞毒性T淋巴细胞实现Fas配体介导的erbB-2表达肿瘤细胞裂解
Cancer Immunol Immunother. 1999 Jan;47(5):278-86. doi: 10.1007/s002620050532.
4
Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma.将小鼠细胞毒性T淋巴细胞重定向用于对抗结肠癌:含TCR-zeta与FcεRI-γ的单链可变域嵌合体具有更高的信号传导效率
J Immunol. 2001 Jan 1;166(1):182-7. doi: 10.4049/jimmunol.166.1.182.
5
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.表达共同递送CD28共刺激的单链抗体受体的细胞毒性T淋巴细胞对同基因结肠癌的排斥反应
J Immunol. 2002 Nov 15;169(10):5780-6. doi: 10.4049/jimmunol.169.10.5780.
6
Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.Fas/Fas配体相互作用在人抗原特异性CD8 + CTL对原发性和转移性结肠癌细胞系的细胞溶解中的差异作用。
J Immunol. 2000 May 1;164(9):4941-54. doi: 10.4049/jimmunol.164.9.4941.
7
A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.一种新型重组单链三特异性抗体可在体外有效募集T淋巴细胞以杀伤癌胚抗原(CEA)阳性肿瘤细胞。
J Biochem. 2004 Apr;135(4):555-65. doi: 10.1093/jb/mvh065.
8
Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.抗独特型抗体在人癌胚抗原转基因小鼠中诱导细胞免疫。
Immunology. 2006 Aug;118(4):483-96. doi: 10.1111/j.1365-2567.2006.02391.x.
9
T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells.经基因工程改造以表达CD16嵌合抗原受体的T淋巴细胞可重定向T细胞免疫反应,使其针对免疫球蛋白G调理的靶细胞。
Cytotherapy. 2016 Feb;18(2):278-90. doi: 10.1016/j.jcyt.2015.10.014. Epub 2015 Dec 17.
10
Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack.干扰素γ对人结肠癌细胞Fas表达调节及其随后对抗原特异性CD8 + 细胞毒性T淋巴细胞攻击敏感性的影响。
Cancer Immunol Immunother. 2000 Jul;49(4-5):193-207. doi: 10.1007/s002620000105.

引用本文的文献

1
Overcoming Intrinsic Resistance of Cancer Cells to CAR T-Cell Killing.克服 CAR T 细胞杀伤癌细胞的内在抵抗性。
Clin Cancer Res. 2021 Dec 1;27(23):6298-6306. doi: 10.1158/1078-0432.CCR-21-1559. Epub 2021 Jul 12.
2
Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same Job.嵌合抗原受体修饰的 T 细胞和 T 细胞结合双特异性抗体:殊途同归。
Curr Hematol Malig Rep. 2021 Apr;16(2):218-233. doi: 10.1007/s11899-021-00628-2. Epub 2021 Apr 30.
3
A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes.
一种新型 Siglec-4 衍生间隔物可改善 CAR T 细胞针对膜近端表位的功能。
Front Immunol. 2020 Aug 7;11:1704. doi: 10.3389/fimmu.2020.01704. eCollection 2020.
4
Combinatorial Immunotherapies for Metastatic Colorectal Cancer.转移性结直肠癌的联合免疫疗法
Cancers (Basel). 2020 Jul 12;12(7):1875. doi: 10.3390/cancers12071875.
5
Emerging CAR T cell therapies: clinical landscape and patent technological routes.新兴的嵌合抗原受体T细胞疗法:临床概况与专利技术路线
Hum Vaccin Immunother. 2020 Jun 2;16(6):1424-1433. doi: 10.1080/21645515.2019.1689744. Epub 2019 Dec 6.
6
Strategies to genetically engineer T cells for cancer immunotherapy.用于癌症免疫治疗的T细胞基因工程策略。
Cancer Immunol Immunother. 2016 Jun;65(6):631-49. doi: 10.1007/s00262-016-1842-5. Epub 2016 May 2.
7
Engineered T cells for cancer treatment.肿瘤治疗用工程化 T 细胞。
Cytotherapy. 2014 Jun;16(6):713-33. doi: 10.1016/j.jcyt.2013.10.002. Epub 2013 Nov 13.
8
Targeted immunotherapy of cancer with CAR T cells: achievements and challenges.嵌合抗原受体 T 细胞治疗肿瘤的靶向免疫治疗:成就与挑战。
Cancer Immunol Immunother. 2012 Jul;61(7):953-62. doi: 10.1007/s00262-012-1254-0. Epub 2012 Apr 22.
9
Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions.嵌合抗原受体 T 细胞免疫疗法:当前的认识和未来方向。
J Gene Med. 2012 Jun;14(6):405-15. doi: 10.1002/jgm.2604.
10
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy.嵌合抗原受体(CAR)修饰的淋巴细胞在癌症治疗中的应用。
Expert Opin Biol Ther. 2011 Jul;11(7):855-73. doi: 10.1517/14712598.2011.573476. Epub 2011 Apr 4.